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Background: Supplemental oxygen is commonly administered to patients in acute care. It 
may cause harm when used inappropriately. Guidelines recommend prescription of acute 
oxygen, yet adherence is poor. We aimed to identify barriers and facilitators to practicing in 
accordance with the evidence-based Thoracic Society of Australia and New Zealand 
(TSANZ) oxygen guideline, and to determine the beliefs and attitudes relating to acute 
oxygen therapy.
Methods: A national cross-sectional survey was conducted. The survey consisted of 3 
sections: (1) introduction and participant characteristics; (2) opinion/beliefs, knowledge 
and actions about oxygen therapy and other drugs; and (3) barriers and facilitators to use 
of the TSANZ guideline. Convenience sampling was employed. A paper-based survey was 
distributed at the TSANZ Annual Scientific Meeting. An online survey was emailed to the 
TSANZ membership and to John Hunter Hospital's clinical staff.
Results: Responses were received from 133 clinicians: 52.6% nurses, 30.1% doctors, and 
17.3% other clinicians. Over a third (37.7%) were unaware/unsure of the oxygen guideline’s 
existence. Most (79.8%) believe that oxygen is a drug and should be treated as one. Most 
(92.4%) stated they only administered it based on clinical need. For four hypothetical cases, 
there was only one where the majority of participants identified the optimal oxygen satura-
tion. A number of barriers and facilitators were identified when asked about practicing in 
accordance with the TSANZ guideline. Lack of oxygen equipment, getting doctors to 
prescribe oxygen and oxygen being treated differently to other drugs were seen as barriers. 
The guideline itself and multiple clinician characteristics were considered facilitators.
Conclusion: There is discordance between clinicians’ beliefs and actions regarding the 
administration of oxygen therapy and knowledge gaps about optimal oxygen therapy in acute 
care. Identified barriers and facilitators should be considered when developing evidence- 
based guidelines to improve dissemination and knowledge exchange.
Keywords: acute oxygen therapy, prescription, COPD
Introduction
Oxygen therapy is commonly used in the acute care setting. Australian data suggest 
that up to 24% of all inpatients1 and up to 79%2 of those admitted with acute 
exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) receive oxy-
gen therapy. In years 2017–2018, there were more than 4.3 million overnight 
admissions to public and private hospitals in Australia,3 with up to one million of 
these patients potentially receiving oxygen therapy. Chronic Obstructive Pulmonary 
Disease (COPD) admissions totaled 64,4953 in the same year, with up to 79% of 
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these patients (50,951) potentially receiving oxygen ther-
apy. While oxygen therapy is a key component in the 
treatment of patients hospitalized with an AECOPD,4,5 
its use is not always optimal6–8 and has the real potential 
to cause harm.9–11 Meta-analysis has shown that liberal 
administration of oxygen therapy to acutely unwell adults 
increases mortality, with the relative risk of in-hospital 
death increasing by 25% for every one percent increase 
in peripheral oxygen saturation (measured by pulse oxi-
meter [SpO2]).12 In COPD these outcomes are even more 
marked, with a 58% reduced risk of death in patients who 
receive titrated oxygen therapy.10 These data highlight the 
importance of appropriate prescription, monitoring and 
administration of oxygen therapy. International guidance 
recommends the prescription of oxygen therapy,9 yet poor 
adherence to these recommendations has been 
highlighted.13
In New South Wales public hospitals, a “Between the 
Flags” system is used with the “Standard Adult General 
Observation” (SAGO) chart to aid in recognizing and 
responding to clinical deterioration.14 This safety system 
requires clinicians to initiate a clinical review when an 
SpO2 falls below 95% unless altered call criteria are 
documented.15 In 2015, the Thoracic Society of Australia 
and New Zealand (TSANZ) released their first evidence- 
based guideline on the use of oxygen therapy for acute 
oxygen use in adults,16 using the National Health and 
Medical Research Council grading system, which was 
founded on evidence base, consistency of evidence, clin-
ical impact, generalizability, and applicability.16 Both the 
TSANZ and British Thoracic Society (BTS) advocate for 
oxygen as a treatment for hypoxemia and not breathless-
ness, and advise that it should be prescribed to a target 
oxygen saturation range of 88%-92%9,16 in those with 
COPD or other chronic respiratory conditions where 
respiratory failure could be suspected. However, they dif-
fer in their recommendations around the target oxygen 
saturation range for those without COPD. The BTS recom-
mended a target range between 94% and 98%9 and the 
TSANZ recommended a target range of 92%-96%.16 Data 
from the 2018 systematic review and meta-analysis by 
Chu et al12 support the recommendations of the 2015 
TSANZ guideline for oxygen to be titrated to a maximum 
SpO2 of 96% but also recommend further research is 
needed to precisely define oxygen therapy strategies that 
maximize benefits and minimize harm. These data further 
add to the growing literature demonstrating that indiscri-
minate administration of oxygen increases mortality, and 
supports conservative administration of oxygen therapy 
across a broad range of acutely ill patients.12
Understanding clinicians perceived barriers or facilita-
tors to the optimal use of acute oxygen therapy is neces-
sary. With this in mind, our aims were to; determine the 
knowledge, beliefs and attitudes relating to acute oxygen 
therapy and prescription across a range of clinicians and to 




A national cross-sectional survey design was employed to 
explore the knowledge, attitudes, and beliefs on the use of an 
evidence-based guideline and identify potential barriers and 
facilitators to practicing in accordance with this guidance.
Setting and Data Collection
Convenience sampling was employed. Participants were 
invited to complete an online or paper-based survey. 
Participants were approached using a variety of methods, 
including email dissemination commencing in 
September 2016 to relevant clinical members of the 
TSANZ, and the John Hunter Hospital, Newcastle 
Australia. Participants were encouraged to forward the 
survey on to any clinicians that they felt may be interested 
in completing it. The survey remained open until 
September 2017. A paper version of the survey was also 
distributed at the 2017 TSANZ Annual Scientific Meeting 
during appropriate COPD sessions. A study-specific 
locked collection box was placed at the TSANZ stand to 
allow collection of anonymous surveys.
Participants
Clinicians (registered or enrolled nurses, doctors, phy-
siotherapists, and paramedics/ambulance workers) who 
were 18 years old or older and who worked in an acute 
care hospital or emergency services were invited to 
participate.
Measures
We surveyed knowledge, attitudes, beliefs, and barriers and 
facilitators of use of an evidence based-guideline: the 2015 
TSANZ guideline for acute oxygen use in adults, 
“Swimming between the flags”.16 Following a review of 
previously designed and validated instruments to investigate 
barriers and facilitators,17–19 no single instrument was 
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deemed suitable for use in this study as they did not explore 
knowledge. Therefore, permission was sought and given to 
amend a previously validated instrument by Peters et al.20
The survey consisted of three sections to provide struc-
ture and enhance participants’ navigation.21,22 Sections one 
and two were developed based on a review of the available 
literature while section three utilized the amended instru-
ment by Peters et al.20 Content and face validity for the 
entire survey were evaluated by a panel of eleven clinicians. 
Following this review, minor amendments were made.
The three sections were:
1. Introduction and participant characteristics: This 
involved a brief introduction, links to participant 
information leaflet and the TSANZ guideline, and 
five closed-ended questions about the participant’s 
demographic data, professional role and experience. 
It also included one open-ended question about the 
participant’s main area of clinical practice.
2. Opinion/beliefs, knowledge and actions about oxy-
gen therapy and other drugs: Questions were 
informed by the aims of this study and a review 
of the literature on oxygen therapy that identified 
knowledge around the delivery of oxygen therapy is 
suboptimal, the prescription of oxygen therapy is 
poor and there is room for improvement in the 
accuracy of oxygen administration and 
monitoring.13 Therefore, 11 closed-ended questions 
explored the opinions/beliefs, knowledge and 
actions of clinicians about the use and prescription 
of oxygen therapy in the acute care setting. 
Clinicians were also asked about their beliefs and 
actions regarding various other drug therapies (oxy-
gen therapy, IV fluids, antibiotics, paracetamol and 
salbutamol) to explore similarities or differences 
when working with these treatments. Following 
this were four hypothetical patient scenarios, 
where participants were asked to indicate the target 
saturation level from 5 multiple-choice options for 
each of the patient cases listed (see Table 3 for case 
scenarios given). Participants were then asked an 
open-ended question on their thoughts about giving 
oxygen therapy for dyspnea.
3. Barriers and facilitators to using the TSANZ 
“Oxygen guideline for acute oxygen use in adults”16 
This section included three open ended questions to 
allow for the expression of opinions and thoughts and 
the remaining 28 questions comprised of a three or 
five point Likert Scale to indicate levels of agreement 
to the 28 statements that explored barriers and facil-
itators to using the TSANZ oxygen guideline using 
a previously validated instrument by Peters et al.20 
The original instrument by Peters et al20 was devel-
oped to identify barriers for implementing innova-
tions and categorized the 28 questions into four 
domains and identified broad categories where either 
a barrier or facilitator may exist, including; innova-
tion (the guideline), context, patient and health care 
practitioner. Accordingly, barriers and facilitators of 
the TSANZ guideline use were categorized into these 
four domains (Survey S1).
Ethics approval was gained from the Hunter New 
England Human Research Ethics Committee 
(Reference: 16/04/20/4.03) and the University of 
Newcastle, Human Research Ethics (Approval: 
H-2016-0222). Participation was voluntary and comple-
tion inferred consent, with participants able to access 
further information on the project via an online link.
Data Analysis
Stata 11, V.14 (Stata Corporation, College Station, Texas, 
USA) software was used for analyzing survey quantitative 
data. Normally distributed variables are reported as mean 
(SD) and non-normal variables as median (interquartile 
range). Frequencies and percentages (%) described the 
categorical data. Chi-squared and Fisher’s exact tests 
were used to investigate associations between categorical 
data as appropriate. P values of less than 0.05 were con-
sidered statistically significant.
The 5-point Likert scale responses were combined in the 
categories “strongly disagree” and “disagree” and “strongly 
agree” and “agree” to analyze the results in three response 
categories to facilitate visual interpretability.
Frequency content analysis was used to code qualita-
tive responses to the free text questions.
Results
Section 1: Participants
Surveys were completed by 133 participants. More than 
a third (37.7%) indicated that they were not aware or were 
unsure if they were aware of the existence of the TSANZ 
guideline on oxygen therapy. Basic demographic data are 
presented in Table 1.
Dovepress                                                                                                                                                         Cousins et al
International Journal of Chronic Obstructive Pulmonary Disease 2020:15                                          submit your manuscript | www.dovepress.com                                                                                                                                                                                                                       



















































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Section 2: Beliefs and Actions of 
Clinicians
Overall, most clinicians (79.8%) believed that oxygen 
therapy is a drug and should be treated like other drugs. 
Fewer (14.3%) believed that it was a drug but should not 
be treated like other drugs and less than four percent 
(3.4%) believed that it was not a drug. Few respondents 
(2.5%) believed that it was not a drug but should be treated 
as one. No significant differences were seen between the 
four professional groups (p=0.074). Most clinicians 
(92.4%) said that they only give oxygen therapy based 
on clinical assessment. Almost six percent (5.9%) stated 
that they either always give oxygen therapy for those who 
are short of breath, or that they know it does not help 
everyone, but it helps most so they always administer it. 
Less than two percent (1.7%) stated they never give oxy-
gen for dyspnea. No significant differences were seen 
between the four professional groups (p=0.194). Free text 
responses to the question “what are your thoughts about 
giving oxygen for dyspnea” were received from 110 parti-
cipants. During content analysis, five themes emerged 
(Table 2) which concurred with the quantitative data. The 
largest number of responses (81 of 110) from clinicians 
suggesting that “clinical assessment and titration to satura-
tions was required” prior to giving oxygen therapy to 
a patient. Clinicians also identified that there were “other 
alternatives to oxygen therapy” for dyspnea, and that oxy-
gen worked as a “placebo” for many patients. Several 
clinicians responded that administration of oxygen “Does 
not help” dyspnea and that instead, it may cause harm 
while fewer clinicians suggested that giving oxygen for 
dyspnea “May help a patient.”
Participants were asked to list how important they 
believed (beliefs) the detailed prescription of oxygen was 
and asked to indicate how often they administer (actions) 
oxygen when no prescription was written. They were also 
asked to do the same for four other medications, IV fluids, 
antibiotics, paracetamol and salbutamol. Figure 1 illus-
trates that overall clinicians' beliefs match their actions 
when it comes to IV fluid and antibiotic prescription and 
administration. Almost 100% agreed that a detailed pre-
scription (Figure 1: 97% for IV fluids and 98% for anti-
biotics) was very important and most (Figure 1: 75% and 
92%, respectively) said they never administered these 
without a prescription. However, the beliefs and actions 
differ when examining the responses for paracetamol, oxy-
gen and salbutamol. Most (Figure 1: 81%-paracetamol; 
87%-salbutamol; 72%-oxygen) believe that a detailed pre-
scription is very important for these three medications, 
fewer said that they never administered these without 
a prescription (Figure 1: 52%; 56% and 21%, respec-
tively). In other words, many administer these medications 
Table 1 Demographic Data
Demographics All Clinicians Nurse Doctor Paramedic Physiotherapist P value
Gender n (%)
Male 49/132 (37.1) 8/70 (11.4) 32/40 (80.0) 7/12 (58.3) 2/10 (20.0) <0.001
Female 83/132 (62.9) 62/70 (88.6) 8/40 (20.0) 5/12 (41.7) 8/10 (80.0)
Country of highest qualification n (%)
Australia 117/133 (88.0) 60/70 (85.7) 35/40 (87.5) 12/13 (92.3) 10/10 (100.0) 0.88
New Zealand 7/133 (5.3) 5/70 (7.1) 1/40 (2.5) 1/13 (7.7) 0/0 (0)
Other 9/133 (6.8) 5/70 (7.1) 4/40 (10.0) 0/13 (0) 0/0 (0)
Years of experience n (%)
<10 years 35/132 (26.5) 15/69 (21.7) 7/40 (17.5) 10/13 (76.9) 3/10 (30.0) <0.001
10–20 years 36/132 (27.3) 14/69 (20.3) 12/40 (30.0) 3/13 (23.1) 7/10 (70.0)
>20 years 61/132 (46.2) 40/69 (58.0) 21/40 (52.5) 0/13 (0) 0/10 (0)
Number of respondents aware of the TSANZ  
Guideline on oxygen therapy n (%)
Yes 66/106 (62.3) 32/55 (58.2) 26/35 (74.3) 0/6 (0) 8/10 (80.0) 0.001
No 31/106 (29.2) 15/55 (27.3) 9/35 (25.7) 6/6 (100) 1/10 (10.0)
Unsure 9/106 (8.5) 8/55 (14.6) 0/35 (0) 0/6 (0) 1/10 (10.0)
Notes: Data calculated on 133 responses; % are for documented values (Non-recorded or not documented values have been treated as missing values); p value denotes 
significant/non-significant difference between the clinical groups. 
Abbreviation: TSANZ, Thoracic Society of Australia and New Zealand.
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Table 2 Selected Exemplars for the Question “What are Your Thoughts About Giving Oxygen for Dyspnoea”
Themes (Number of Responses/ 
Total Responses)
Clinician Responses (Professional Group)
Clinical assessment and titration to 
saturations required (81/110)
“Oxygen therapy should not be used to relieve the symptom of dyspnoea. It should only be given to patients 
with hypoxaemia with careful titration to a target oxygen saturation range” (Doctor) 
“If the dyspnoea is associated with hypoxia then supplemental oxygen is suitable. Dyspnoea does not equal 
hypoxia and oxygen should not be given for dyspnoea alone” (Doctor) 
“It would depend on the patient’s clinical situation and the assessment of the current situation . . . If the 
patient is hypoxic then I would give O2 to maintain SpO2>90–95%.” (Nurse) 
“Dyspnoea does NOT mean lack of oxygen. Only where the clinical indications exist for a deficiency of 
oxygen uptake should oxygen be administered, especially in doses above 2L” (Nurse) 
“Oxygen therapy is not always beneficial to all patients. You need to assess the patient on their presentation, complaint 
& history & then use your observations as adjuncts to appropriate administration of any medication . . .” (Paramedic) 
“If it is indicated for the patient from their assessment then I will titrate a dose until I am satisfied with the patient’s 
condition” (Paramedic) 
“If there is a clinical indication and patient benefit then definitely try (art and science)” (Physiotherapist)
Does not help and may cause harm (21/110) “As a rule, I do not encourage it . . . I emphasise it is a treatment of hypoxaemia, not breathlessness, and 
these are different things. Amongst inpatients, I find it a barrier to mobilisation” (Doctor) 
“Not useful under any circumstance” (Doctor) 
“Too much oxygen can be as bad as not enough. Hypoxia is usually not the cause for dyspnoea and giving 
oxygen may not be helpful but may be harmful . . . ” (Doctor) 
“Overused in patients who will not benefit and may be harmed” (Doctor) 
“It doesn’t work” (Doctor) 
“That if given to certain patients it can actually cause more harm than good and cause the patient’s wellbeing 
to deteriorate quickly if used inappropriately” (Nurse) 
“Like any medication I use I need a reason to give O2. I don’t just give it to everyone. For some it can do 
harm so giving it in this setting is terrible patient care” (Paramedic)
May help the patient (17/110) “There is a minimal short-term effect on reducing drive to breathe that probably aids in managing dyspnoea, 
though may be no better than enhanced flow of air alone” (Doctor) 
“Has some benefit due to reduced ventilatory drive” (Doctor) 
“Useful in initial treatment whilst identifying cause and preparing treatment” (Nurse) 
“Anxiety and dyspnoea are inseparable, so the giving of O2 helps both but needs to be used with caution” (Nurse) 
“It can be useful” (Nurse) 
“Particularly during exercise, O2 therapy should be given to relieve dyspnoea if it increases activity/exercise levels 
and to prevent desaturation” (Physiotherapist)
There are other alternatives to oxygen 
therapy (14/110)
“Does not make any physiological sense. A handheld fan would derive the same benefit” (Doctor) 
“In combination with other interventions. Repositioning. Encouraging them to focus on slowing their 
breathing. PRN Neb may be suitable. Oxygen should be used with caution for COPD patients” (Nurse) 
“Potentially harmful: much better to provide a fan or similar” (Nurse) 
“After clinical assessment, oxygen can be given for dyspnoea along with other interventions e.g. Positioning” (Nurse) 
“Oxygen is usefully if SpO2 is less than 94% however there are other techniques such as sitting patient up, leaning 
patient foreword etc. would/should be done in conjunction with O2 [SIC] if required” (Nurse)
Placebo (13/110) “Patients who present to the ED very distressed with dyspnoea say they feel much better with oxygen. 
Generally, this is the patients who are hypoxic. Need to be careful [SIC] with patients who retain CO2” (Doctor) 
“Not clinically proven however if the patient feels it helps sometimes it’s efficacy can’t be argued!” (Nurse) 
“There is not always a clinical benefit, but in some patients, there can be a powerful placebo effect” (Nurse) 
“It can be reassuring to the breathless patient that something is being done while the cause of the breathlessness is 
being sought” (Nurse) 
“Often difficult to do nothing. Patients usually like to have oxygen if they feel short of breath” (Paramedic) 
“Some evidence so shouldn’t be used in all cases, but anecdotally works for many patients + placebo effect in some 
to relieve anxiety-related dyspnoea” (Physiotherapist)
Note: Some responses were categorized under multiple themes due to the nature or length of the response.
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when there was no prescription written. In the case of 
oxygen therapy, 72% stated that they believed that 
a prescription was very important; however, nearly 80% 
stated that they either always or sometimes gave oxygen 
even without a prescription.
Knowledge Related to Oxygen Therapy
Participants were asked to indicate the target saturation 
level for four hypothetical patient scenarios (Table 3). 
Overall, the only scenario where a patient’s optimal satura-
tion was identified by more than 50% of the participants 
was that of “Mr Riley”, who was clearly identified as 
a COPD patient. More than two-thirds (69.6%) of the 
participants identified the recommended saturation range 
(88–92%). The optimal saturation target was identified by 
approximately a quarter of participants for the remaining 
scenarios.
Section 3: Barriers and Facilitators
Barriers where respondents agreed or strongly agreed with 
the statement in greater proportions to those who disagreed 
have been listed in Table 4. Similarly, facilitators where 
respondents disagreed or strongly disagreed with the state-
ment in greater proportions to those who agreed are also 
listed in Table 4. Barriers to implementing the guideline 
included lack of available equipment (i.e. correct oxygen 
equipment), difficulties in getting doctors to prescribe 
oxygen therapy, identification that oxygen was not treated 
with the same care as other drugs and poor administration 
and monitoring of oxygen therapy by nurses were all 
identified as barriers to guideline implementation. While 
similar numbers of clinicians read and remembered the 
guideline (41%) when compared to those who stated that 
they did not read or remember the guideline (46%). This is 
a similar result to an earlier question that asked whether 
participants were aware of the guideline, where 38% stated 
that they were not aware or were unsure if they were 
aware of the guideline (Table 1). The number of clinicians 
who indicated that they had not read or remembered the 
guideline do present as a barrier.
The guideline itself (innovation) and multiple clinician 
(care provider) characteristics were considered facilitators to 
implementing the TSANZ oxygen guideline (Table 4). 
These clinician characteristics identified that respondents 
believed that they did not resist working with protocols, 
did not have difficulty in changing their routines or did not 
find it difficult to work with the guideline because they had 
not been involved in setting up the practice change (84%, 
Figure 1 Beliefs and actions in relation to various drug therapies. 
Note: Reported percentages are rounded to whole numbers.
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81% and 69%, respectively). They also demonstrated agree-
ment with the guideline itself by disagreeing with the state-
ment “an SpO2 level of 92% is too low for most patients” 
and that “It is difficult to provide evidenced-based care to 
patients who are acutely short of breath who appear to need 
more oxygen than the guideline recommends.” (77% and 
56%, respectively). However, when asked if they believed 
that parts of the guideline were incorrect 49% indicated that 
they were unsure by neither agreeing or disagreeing with the 
statement and 50% disagreeing with the statement. The 
majority felt that the guideline concepts were consistent 
with their training and that they were adequately trained 
(76% and 72%, respectively).
When asked if organizational policies prevent the use 
of the guideline, clinicians were asked to give an example 
if they agreed or strongly agreed with the statement. Fewer 
(22%) clinicians agreed or strongly agreed with the state-
ment than disagreed or strongly disagreed (30%). Of those 
who agreed, 20 clinicians offered further detail and exam-
ples. The most common response related to organization’s 
use of the “Standard Adult General Observation” (SAGO) 
chart and “Between the flags” protocols. The SAGO chart 
requires initiation of a clinical review if an SpO2 ≥95% is 
not maintained. This does not align with the current 
recommendations provided by the TSANZ who advocate 
to maintain an SpO2 above 92% for most patients. 
Clinicians' comments highlight the difficulties experienced 
in using the SAGO chart. Examples of these comments are 
highlighted in Table 5.
Discussion
Findings from this study identify that clinicians believe 
that oxygen is a drug and should be treated like other 
drugs. It is importantly demonstrated however that knowl-
edge around the most appropriate oxygen saturation levels 
for patients with a variety of medical conditions is 
Table 3 Case Scenarios













Mr Riley, a 56-year-old male admitted to hospital with an acute exacerbation of COPD
SpO2 88–92% 80/115 (69.6) 8/9 (88.9) 40/59 (67.8) 25/37 (67.6) 7/10 (70.0) 0.39
SpO2 90–94% 21/115 (18.3) 0/9 (0.0) 11/59 (18.6) 9/37 (24.3) 1/10 (10.0)
SpO2 > 92% 7/115 (6.1) 1/9 (11.1) 2/59 (3.4) 3/37 (8.1) 1/10 (10.0)
SpO2 > 94% 3/115 (2.6) 0/9 (0.0) 2/59 (3.4) 0/37 (0.0) 1/10 (10.0)
SpO2 > 95% 4/115 (3.5) 0/9 (0.0) 4/59 (6.8) 0/37 (0.0) 0/10 (0.0)
Samantha Hood, a 22-year-old lady admitted with acute asthma
SpO2 88–92% 2/115 (1.7) 0/9 (0.0) 2/58 (3.5) 0/38 (0.0) 0/10 (0.0) 0.093
SpO2 90–94% 14/115 (12.2) 0/9 (0.0) 5/58 (8.6) 9/38 (23.7) 0/10 (0.0)
SpO2 > 92% 22/115 (19.1) 1/9 (11.1) 12/58 (20.7) 8/38 (21.1) 1/10 (10.0)
SpO2 > 94% 30/115 (26.1) 6/9 (66.7) 12/58 (20.7) 10/38 (26.3) 2/10 (20.0)
SpO2 > 95% 47/115 (40.9) 2/9 (22.2) 27/58 (46.6) 11/38 (29.0) 7/10 (70.0)
Lois Lane, 82-year-old lady who is day 1 post right hip replacement with no other co-morbidities
SpO2 88–92% 2/114 (1.8) 1/9 (11.1) 0/57 (0.0) 1/38 (2.6) 0/10 (0.0) <0.001
SpO2 90–94% 19/114 (16.7) 1/9 (11.1) 6/57 (10.5) 11/38 (29.0) 1/10 (10.0)
SpO2 > 92% 32/114 (28.1) 0/9 (0.0) 12/57 (21.1) 19/38 (50.0) 1/10 (10.0)
SpO2 > 94% 29/114 (25.4) 4/9 (44.4) 14/57 (24.6) 6/38 (15.8) 5/10 (50.0)
SpO2 > 95% 32/114 (28.1) 3/9 (33.3) 25/57 (43.9) 1/38 (2.6) 3/10 (30.0)
Tom Baker, 81-year-old obese man (BMI 32) who currently smokes. He is day 4 post cholecystectomy
SpO2 88–92% 29/115 (25.2) 1/9 (11.1) 12/58 (20.7) 12/38 (31.6) 4/10 (40.0) 0.027
SpO2 90–94% 32/115 (27.8) 4/9 (44.4) 12/58 (20.7) 14/38 (36.8) 2/10 (20.0)
SpO2 > 92% 24/115 (20.9) 2/9 (22.2) 13/58 (22.4) 7/38 (18.4) 2/10 (20.0)
SpO2 > 94% 16/115 (13.9) 2/9 (22.2) 7/58 (12.1) 5/38 (13.16) 2/10 (20.0)
SpO2 > 95% 14/115 (12.2) 0/9 (0.0) 14/58 (24.1) 0/38 (0.0) 0/10 (0.0)
Notes: where answers were listed that did not appear as part of the options, these have been treated as missing variables; n = number of respondents who chose scenario 
over total responses; p value denotes significant/non-significant difference between various clinical groups. Pseudonyms have been used in the hypothetical scenarios.
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Table 4 Barriers and Facilitators to Practicing in Accordance with the TSANZ Guideline













It is difficult to provide EBC when the equipment needed is not available 
(Context)
12% 11% 77% 102
It is difficult to provide EBC to patients because it is difficult to get doctors to 
consistently and accurately prescribe oxygen therapy (Care Provider)
10% 16% 74% 100
It is difficult to provide EBC to patients because oxygen is not considered 
or treated with the same care as other drugs (Care Provider)
20% 16% 64% 100
If there are not enough supportive staff, it is difficult to provide EBC (Care 
provider)
29% 16% 55% 100
It is difficult to provide EBC to patients because nurses do not administer 
or monitor oxygen with enough care (Care Provider)
28% 17% 55% 100
Did not read or remember the TSANZ guideline (Care Provider) 41% 13% 46% 105
I wish to know more about the TSANZ guideline before I decide to apply 
it (Care Provider)
31% 24% 45% 106
It is difficult to provide EBC to patients who do not know what their 
diagnosis is (Patient)
40% 15% 44% 99
Facilitators
I have a general resistance to working according to protocols (Care Provider) 84% 9% 7% 102
I have difficulty in changing my old routines (Care Provider) 81% 11% 8% 105
It is difficult to provide EBC to patients because an SpO2 level of 92% is 
too low for most patients (Care Provider)
77% 13% 10% 99
It is difficult to provide EBC to patients because this differs with basic 
concepts taught during my training (Care Provider)
76% 20% 4% 98
It is difficult to provide EBC because I am not sufficiently trained (Care 
Provider)
72% 13% 15% 100
The TSANZ guideline is not a good starting point for my self-study 
(Innovation)a
71% 27% 2% 106
It is difficult to provide EBC because I have not been involved in setting up 
the practice change (Care Provider)
69% 19% 12% 101
The TSANZ guideline does not fit into my ways of working in practice 
(Innovation)
59% 40% 1% 101
It is difficult to provide EBC to patients who are acutely short of breath who 
appear to need more oxygen than the guideline recommends (Care Provider)
56% 22% 22% 100
Working with the TSANZ guideline is too time consuming (Innovation) 51% 46% 3% 101
I think parts of the guideline are incorrect (Care Provider) 50% 49% 1% 102
It is difficult to provide EBC to patients who have not had an Arterial 
Blood Gas taken (Context)
44% 13% 43% 100
Notes: The reported percentages are rounded to whole numbers; aThe positive phrasing of this statement has been reversed for consistency in presentation. 
Abbreviations: EBC, evidenced-based care; SOB, short of breath; TSANZ, Thoracic Society of Australia & New Zealand.
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suboptimal and should be improved. This study identified 
several barriers and facilitators to the utilization of this 
evidence-based guideline. Many of these barriers and 
facilitators related to the clinicians themselves while the 
guideline itself was seen to be a facilitator to adoption. 
Both the “context of care” (equipment available) and the 
“patient” (patients who do not know what their diagnosis 
is) were seen as a barrier.
Appropriate oxygen delivery like any health-care prac-
tice requires the utilization and uptake of evidence-based 
guidelines. Effective translation of evidence into clinical 
practice requires an understanding of the barriers and 
facilitators23 and this study may assist in providing gui-
dance on how to best facilitate the translation of this 
commonly used therapy into clinical practice to ultimately 
improve patient outcomes.
This national study has demonstrated that knowledge 
about the TSANZ guideline content was sub optimal. 
There is scope for improvements in disseminating this 
evidence to clinicians and promoting its existence and 
importance. Most clinicians believed that oxygen is 
a drug and should be treated like other drugs. Our data 
demonstrate a shift in attitudes towards administering oxy-
gen for dyspnea when compared to other studies.24,25 
While the use of oxygen for dyspnea appears to be less 
common, efforts to educate those who continue to use it as 
a treatment for dyspnea alone needs to continue. Free text 
responses revealed that several clinicians believe that oxy-
gen is useful as a placebo or that it may help the patient. 
A previous qualitative study26 identified that oxygen was 
used by clinicians as a cure-all. Like our findings, “anxi-
ety” or its use as a placebo was commonly cited as 
a reason for giving oxygen.
There were variations between clinicians’ beliefs and 
actions for the different drug therapies listed. Both IV 
fluids and antibiotics were treated similarly. This was not 
true for the other drugs. Both paracetamol and salbutamol 
are “over the counter” medications in Australia. They are 
also considered “nurse-initiated medications” in many 
acute care settings and must be administered and docu-
mented according to hospital policy. Oxygen therapy is 
also considered a “nurse-initiated medication”; however, 
its administration does not require documentation on 
a medication chart and this may, in part, explain why 
beliefs and actions do not match for the use of oxygen 
therapy. These comparative data provide insightful knowl-
edge about the perception of oxygen in comparison with 
other commonly used medications in the acute care 
setting.
Previous studies exploring beliefs and actions in critical 
care areas27–29 have demonstrated variability in oxygen 
therapy practice. Small et al30 compared the use and misuse 
of oxygen compared to antibiotics in an inpatient cohort in 
1990 and demonstrated that oxygen therapy was not pre-
scribed or administered with the same care as that given to 
antibiotics. Highlighting that this is a longstanding problem 
with little change in behavior over time. Most clinicians in 
our study rated the importance of a written prescription as 
very high for all the medications listed. It is not clear why 
Table 5 Selected Exemplars for the Question “if You Agree or 
Strongly Agree That Organizational Policies Prevent the Use of 
This Guideline, Please Give an Example.”
Clinician Responses (Professional Group)
“The guideline is not easily accessible at the point of care” (Doctor) 
“Our organisation ONLY promotes between the flags and dismisses 
attempts to use TSANZ guidelines” (Doctor) 
“At the institution I work at, an SpO2 of <94% is considered 
‘abnormal’ and warrants clinical review. Whereas, the TSANZ 
guidelines recommend a target of 92–95%. To implement these 
guidelines would require an alteration of a patients ‘Clinical Review 
Criteria’, which would not be feasible for every single inpatient 
admitted to hospital” (Doctor) 
“Current DETECT parameters make few provisions for patients at 
risk for hypercapnia [SIC]” (Doctor) 
“Between the flags standardisation of normal sats >95% make things 
very difficult” (Doctor) 
“The SAGO chart, with ‘between the flags’ has no facility to alter the 
amount of oxygen that should be given to a patient, only to alter the 
respiratory rate or saturations that prompt a clinical review. This 
makes delivering of appropriate oxygen supplementation 
inappropriate and dangerous. E.g. SpO2 >96% so not requiring review 
(but needing 15L via NRBM to achieve this)” (Doctor) 
“Our ‘SAGO’ does not have adjustable ‘white’ zone. So, targets ≥ 95%  
SaO2 for all patients” (Nurse) 
“The CEC BTF guidelines provide discretionary space for care 
providers to adjust oxygen and improve SpO2 rather than initiating 
a clinical review to assess the underlying cause of hypoxaemia” 
(Nurse) 
“Between the flags’ standard protocol conflicts the evidence-based 
consensus guidelines” (Nurse) 
“Not updated regularly enough” (Nurse) 
“Ambulance protocols are sometimes outdated and I do not know if 
they follow the therapeutic guidelines” (Paramedic) 
“Between the Flags” Altered calling criteria helps somewhat to 
reduce obstruction to correct oxygen administration” (Nurse)
Abbreviations: TSANZ, Thoracic Society of Australia and New Zealand; 
DETECT, Detecting deterioration, Evaluation, Treatment, and Communicating in 
Teams is part of the “between the flags” program; Between the flags, between the 
flags system is a NSW public health initiative aid in recognizing and responding to 
clinical deterioration; NRBM, non-rebreather mask; SAGO, Standard Adult General 
Observation Chart; CEC BTF, Clinical Excellence Commission Between the Flags.
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differences exist between the different drug groups with 
respect to clinician actions, but not for clinician beliefs. It 
is possible that because both IV fluids and antibiotics are 
prescription-only medications, there is appropriate reluc-
tance to administer these without a valid prescription. In 
addition, clinicians may administer oxygen therapy (with-
out a prescription) to improve oxygenation in patients who 
are hypoxic. Many studies have shown that the prescription 
of oxygen is poor31–34 and to withhold oxygen therapy 
when it is needed, due to a lack of a valid prescription 
would be poor practice and potentially negligent. Oxygen 
however does need to be treated with the same consistency 
as other medications (i.e. paracetamol, intravenous fluids).
Gaps in knowledge were identified in relation to the 
optimal target saturation level (based on the TSANZ guide-
line) for fictitious patient scenarios. For the COPD patient 
scenario, our results were similar to those found by 
O’Driscoll et al35 where 65.6% of clinicians correctly identi-
fied a target saturation range of 88–92%. For the case where 
the patient is admitted with asthma, the TSANZ guideline16 
recommends a range of 92–96% in “other acute medical 
conditions” but also states “there is an evidence base for 
titration of oxygen therapy to a target SpO2 range of 
93–95% in acute severe asthma . . . ” (p1188). The options 
listed in the survey were 88%-92%, 90%-94%, >92%, >94% 
and >95%. Of these >94% is the only one that is reflective of 
the background evidence presented in this guideline by the 
TSANZ. Yet only a quarter of respondents chose this 
response. The final case scenario was an 81-year-old obese 
man who smoked, placing him at risk of hypercapnia. Most 
clinicians did not identify that this patient was at risk of 
carbon dioxide (CO2) retention and chose saturations levels 
that may have resulted in him receiving too much oxygen. 
We acknowledge that there are no specific recommendations 
that discuss obesity (aside from identifying that obesity 
hyperventilation syndrome is associated with chronic 
respiratory failure) or smoker status in the TSANZ 
guideline.16 However, the BTS advises that those with mor-
bid obesity be treated in a similar manner to those with 
COPD.9 This is a potential area where further guidance 
could be given. Considering that more than 31% of 
Australians are obese,36 with a growing trend towards an 
overweight and obese society, further education on the pul-
monary risk factors associated with obesity is prudent.
Across all four case studies, the average response rate 
that most closely reflected the TSANZ guideline was 37%. 
This is significantly lower than the average reported by 
O’Driscoll et al.35 Clinicians in their study achieved an 
average correct answer rate of 70%. Authors acknowl-
edged that clinicians in the areas surveyed may have 
been better informed than was typical due to a drive to 
optimize oxygen therapy locally.35 A number of previous 
studies37–39 have demonstrated gaps in knowledge of 
health-care staff in relation to various aspects of oxygen 
therapy. Johnson et al40 examined the TSANZ oxygen 
guideline, listing 15 individual areas where knowledge 
would be necessary to provide best care to patients receiv-
ing oxygen therapy. While this paper was directed at nur-
sing staff, it would not be unreasonable to draw parallels to 
other clinical specialties. All health-care professionals who 
administer, monitor or care for patients who require oxy-
gen therapy should have a high level of skill and knowl-
edge when using oxygen, particularly considering the large 
number of patients who receive this therapy.1,2 Efforts to 
improve knowledge and skill are a priority.
We recognize that the educational background and 
expertise vary greatly between different clinical groups 
and consideration of these differences may be prudent 
when guideline development and dissemination is under-
taken to provide more specific and focused information. 
Producing guideline documents that target various clinical 
groups and stakeholders by providing discipline-specific 
summaries (as the Stroke Foundation41 of Australia have 
done) could be considered.
Most barriers and facilitators uncovered in this study 
fell under the ‘care provider’ category, highlighting that 
efforts to improve the uptake of this and other guidelines 
should focus on clinicians themselves. Barriers related to 
difficulties in getting doctors to prescribe oxygen therapy 
and in getting nurses to administer and monitor those with 
oxygen therapy. It was also identified that oxygen was not 
considered or treated with the same care as other drugs. 
Cousins et al13 have previously highlighted the low rates 
of oxygen prescription and discussed the challenges for 
increasing prescription rates in clinical practice. 
Heartshorne et al42 demonstrated sustained improvements 
in rates of oxygen prescription during their pilot study that 
utilized multiple methods designed to improve practice. 
Similar strategies need to be implemented across Australia 
to encourage change in doctor’s prescription practices and 
improve administration and monitoring by nursing staff.
Most clinicians believe that they are adequately 
trained, which would facilitate the implementation of the 
TSANZ guideline. However, these results are not necessa-
rily supported by the answers given in the clinical scenar-
ios. Nonetheless, almost a quarter of surveyed clinicians 
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believe they had not been or were unsure if they were 
adequately trained in the use of oxygen therapy and that 
the concepts within the TSANZ guideline differed from 
those taught during basic training. This points to areas for 
improvement in clinician training at both the undergradu-
ate and postgraduate levels. Most staff agreed that this 
guideline was a good starting point for self-study, and 
consideration could be given to developing structured 
and intentional learning material that may facilitate guide-
line dissemination and contribute towards staff learning 
activities and the accumulation of the mandatory continu-
ing professional development points required for ongoing 
health professional registration in Australia. This is an 
important point when considering implementation of new 
knowledge. Merely providing information is not enough. 
Guidelines require a multifaceted dissemination pathway 
for adequate uptake,43 and focus needs to be placed on this 
aspect of knowledge exchange.
Most barriers and facilitators aligned across the profes-
sional groups. There were a number of exceptions worth 
noting; both nurses and doctors indicated that nurses do not 
administer or monitor oxygen with enough care; however, 
paramedics and physiotherapists disagreed with this state-
ment. This is not a surprising finding considering nurses and 
doctors would have more day to day involvement in ensur-
ing the patients under their care are receiving appropriate 
oxygen therapy. The second barrier where there was dis-
cordance among the professional groups was to the state-
ment “It is difficult to provide evidence-based care to 
patients who do not know what their diagnosis is.” 
Overall, 44% agreed while 40% disagreed with this state-
ment; however, far more doctors disagreed with this state-
ment (52%) when compared to those who agreed (32%). 
Considering doctors are responsible for the diagnosis of 
a patient’s medical condition, a patient’s inability to state 
their diagnosis understandably does not appear to provide 
a barrier to treatment for doctors. Items to note where 
differences were demonstrated for the facilitators between 
the clinical groups were with the statement “The TSANZ 
oxygen guideline . . . does not fit into my ways of working 
in practice.” Paramedics indicated that they neither agreed 
nor disagreed when compared to other clinicians who dis-
agreed. The second item where differences were demon-
strated where with the statement “working with the TSANZ 
guideline . . . is too time consuming.” Nurses and phy-
siotherapists disagreed with this statement while the major-
ity of doctors and paramedics responded that they neither 
agreed nor disagreed indicating that they were unsure about 
this question (Table S1 – Supplement 1).
This study has strengths and limitations. To our knowl-
edge, it is the only Australian study that has captured 
views from a variety of clinical groups and explored the 
beliefs and attitudes to the prescription of oxygen therapy 
and the barriers and facilitators for using the TSANZ 
oxygen guideline. We acknowledge that health-care pro-
fessional education, expertise and perspectives vary 
greatly between specialties and that the generic nature of 
the survey may have missed pertinent data relating more 
specifically to individual professional groups. However, 
each of these specialties administers and/or prescribes 
oxygen therapy in clinical settings in Australia and we 
believe that questions were broad enough to capture 
beliefs and attitudes of these different clinicians, and 
where differences exist these have been highlighted. 
While the small cohort presents limitations, particularly 
in that it may not be representative of clinicians views 
outside of Australia or those who work outside of respira-
tory medicine, the large body of evidence related to poor 
practice in relation to oxygen therapy suggests that these 
views may be more widely spread that what we have been 
able to capture.
Our data support those of other studies that have 
demonstrated that there is scope to improve the knowledge 
of various factors in relation to oxygen therapy and the 
appropriate amounts of oxygen that are administered to 
various patient groups. Clinicians overwhelmingly 
believed that oxygen was a drug and should be treated 
like other drugs. However, many did not treat oxygen with 
the same level of care or caution as they did other com-
monly used medications like antibiotics or IV fluids. 
Further studies in this area would shed light on why such 
wide variations exist in relation to the actions of clinicians 
when administering different medications.
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poster presentation at the TSANZSRS Annual Scientific 
Meeting 2020 (postponed due to COVID-19). The abstract 
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